Linoleic Acid-Based Transferosomes for Topical Ocular Delivery of Cyclosporine A

被引:11
|
作者
Uwaezuoke, Onyinye [1 ]
Du Toit, Lisa C. [1 ]
Kumar, Pradeep [1 ]
Ally, Naseer [2 ]
Choonara, Yahya E. [1 ]
机构
[1] Univ Witwatersrand, Fac Hlth Sci, Sch Therapeut Sci, Dept Pharm & Pharmacol,Wits Adv Drug Delivery Pla, 7 York Rd, ZA-2193 Johannesburg, South Africa
[2] Univ Witwatersrand, Dept Neurosci, Div Ophthalmol, 7 York Rd, ZA-2193 Johannesburg, South Africa
基金
新加坡国家研究基金会;
关键词
topical ocular drug delivery; transferosomes; linoleic acid; cyclosporine A; nanoparticle drug-delivery systems; IN-VITRO; BARRIER PROPERTIES; CORNEAL; NANOPARTICLES; PENETRATION; EYE; BEHAVIOR; VIVO; ABSORPTION; SYSTEMS;
D O I
10.3390/pharmaceutics14081695
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Delivering high-molecular-weight hydrophobic peptides, such as cyclosporine A, across the corneal epithelium remains a challenge that is complicated by other physio-anatomical ocular structures that limit the ocular bioavailability of such peptides. Transferosomes have previously been used to improve transdermal permeability, and have the potential for improving the ocular corneal permeability of applicable drugs. In this study, transferosomes for the potential ocular delivery of cyclosporine A were investigated. Linoleic acid was evaluated for its effect on the stability of the transferosomes and was substituted for a portion of the cholesterol in the vesicles. Additionally, Span (R) 80 and Tween (R) 80 were evaluated for their effect on transferosome flexibility and toxicity to ocular cells as edge activators. Attenuated Total Reflectance-Fourier Transform Infrared spectroscopy (ATF-FTIR), differential scanning calorimetry (DSC), and dynamic light scattering (DLS) were used to evaluate the physicochemical parameters of the blank and the cyclosporine A-loaded transferosomes. Cyclosporine A release and corneal permeability were studied in vitro and in a New Zealand albino rabbit corneal model, respectively. The linoleic acid contributed to improved stability and the nano-size of the transferosomes. The Tween (R)-based formulation was preferred on the basis of a more favorable toxicity profile, as the difference in their corneal permeability was not significant. There was an initial burst release of cyclosporine A in the first 24 h that plateaued over one week. The Tween (R)-based formulation had a flux of 0.78 mu g/cm(2)/h. The prepared transferosomes demonstrated biocompatibility in the ocular cell line, adequately encapsulated cyclosporine A, ensured the corneal permeability of the enclosed drug, and were stable over the period of investigation of 4 months at -20 degrees C.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Advances in Hyaluronic Acid-Based Drug Delivery Systems
    Jiao, Yan
    Pang, Xin
    Zhai, Guangxi
    [J]. CURRENT DRUG TARGETS, 2016, 17 (06) : 720 - 730
  • [32] Hyaluronic Acid-Based Nanocarriers for Anticancer Drug Delivery
    Fu, Chao-Ping
    Cai, Xing-Yu
    Chen, Si-Lin
    Yu, Hong-Wei
    Fang, Ying
    Feng, Xiao-Chen
    Zhang, Li-Ming
    Li, Chang-Yong
    [J]. POLYMERS, 2023, 15 (10)
  • [33] Nanostructured Hyaluronic Acid-based Materials for the Delivery of siRNA
    Shah, Keval
    Chawla, Sunita
    Gadeval, Anuradha
    Reddy, Goutham
    Maheshwari, Rahul
    Kalia, Kiran
    Tekade, Rakesh Kumar
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (23) : 2678 - 2691
  • [34] Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone
    Kalam, Mohd Abul
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2016, 89 : 127 - 136
  • [35] Oleic acid-based vesicular nanocarriers for topical delivery of the natural drug thymoquinone: Improvement of anti-inflammatory activity
    Bruno, Maria Chiara
    Gagliardi, Agnese
    Mancuso, Antonia
    Barone, Antonella
    Tarsitano, Martine
    Cosco, Donato
    Cristiano, Maria Chiara
    Fresta, Massimo
    Paolino, Donatella
    [J]. JOURNAL OF CONTROLLED RELEASE, 2022, 352 : 74 - 86
  • [36] Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment
    Jiang, Hui
    Xu, Zhuping
    [J]. DRUG DELIVERY, 2023, 30 (01)
  • [37] Application of topical 2% cyclosporine A in inflammatory ocular surface diseases
    Asena, Leyla
    Altinors, Dilek Dursun
    [J]. INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (11) : 3943 - 3952
  • [38] Pan-European survey of the topical ocular use of cyclosporine A
    Labbe, A.
    Baudouin, C.
    Ismail, D.
    Amrane, M.
    Garrigue, J. -S.
    Leonardi, A.
    Figueiredo, F. C.
    Van Setten, G.
    Labetoulle, M.
    [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2017, 40 (03): : 187 - 195
  • [39] Application of topical 2% cyclosporine A in inflammatory ocular surface diseases
    Leyla Asena
    Dilek Dursun Altınörs
    [J]. International Ophthalmology, 2023, 43 : 3943 - 3952
  • [40] Frequent Dosing of Topical Cyclosporine A for Severe Ocular Surface Disease
    Gire, Anisa I.
    Karakus, Sezen
    Ingrodi, Shanna M.
    Akpek, Esen Karamursel
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 32 (03) : 150 - 154